MedTrace Logo

Neurophysiology of Weakness and Exercise in Rotator Cuff Tendinopathy

NCT02971072 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2022-09-13

No results posted yet for this study

Summary

The purpose of this study is to examine deficits in activation and motor patterns, as well as central drive in patients with rotator cuff tendinopathy. There are three specific aims: (1) determine the effect of acute pain relief on rotator cuff muscle activation in patients with rotator cuff tendinopathy, (2) determine the effect of exercise on rotator cuff muscle activation in patients with rotator cuff tendinopathy, and (3) compare rotator cuff muscle activation between patients with rotator cuff tendinopathy and healthy controls.

Conditions

  • Acute Pain
  • Atrophic
  • Goals
  • Impairment
  • Infiltration
  • Injury
  • Muscle Weakness
  • Pain
  • Pathology
  • Shoulder Pain
  • Syndrome
  • Tendinopathy

Interventions

PROCEDURE

Subacromial injection

A subacromial injection consisting up 6 cc 0.5% Marcaine with Epinephrine and 1 cc DepoMedrol will be administered.

OTHER

Physical Therapy

A standardized six-week exercise protocol supervised by a physical therapist

Sponsors & Collaborators

  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

    collaborator NIH

  • University of Oregon

    lead OTHER

Principal Investigators

  • Andrew R Karduna, PhD · University of Oregon

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2021-04-30
Completion
2021-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02971072 on ClinicalTrials.gov